NCT02400775View on ClinicalTrials.gov

A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Essential Hypertension With Stable Angina and Dyslipidemia
Interventions
DRUG

Azilsartan

Azilsartan tablets

Trial Locations (1)

Unknown

Tokushima

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY